DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Uemura H, Uchida Y, Kouyama JI. , et al.
Real-world efficacy of glecaprevir plus pibrentasvir for patients with HCV with or without prior DAA therapies: evaluation by deep sequencing for HCV strains with NS5A RAS.
Hepatology 2018;
68 (Suppl.): 402A
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.